LMNXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (1 1月 1970 @ 09:00):

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide...

Stats
本日の出来高	1.02M
平均出来高	650 237
時価総額	0.00
EPS	$0 ( 2021-08-02 )
Last Dividend	$0.100 ( 2021-06-16 )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.188 (0.51%)

Insider Trading

Date	Person	Action	Amount	type
2021-07-14	Ogunro Edward A	Sell	10 760	Common Stock
2021-07-14	Ogunro Edward A	Sell	50 133	Common Stock
2021-07-14	Mcnamara Kevin M	Sell	24 443	Common Stock
2021-07-14	Mcnamara Kevin M	Sell	75 925	Common Stock
2021-07-14	Erickson Thomas W	Sell	79 204	Common Stock

INSIDER POWER
0.00
Last 100 transactions
Buy: 1 457 367 \| Sell: 3 933 642

ボリューム相関

長: 0.06 (neutral)

短: 0.88 (strong)

Signal:(63.839) Same movement expected

Luminex Corporation 相関

10 最も正の相関
DSPG	0.935
CCRC	0.923
TVTY	0.893
STAY	0.893
IQ	0.89
AUGX	0.887
PUCK	0.882
ACAH	0.882
SKYX	0.875
CROX	0.875

10 最も負の相関
ODT	-0.927
TCDA	-0.921
XPDI	-0.911
EYEG	-0.91
ENPH	-0.901
GRAY	-0.895
LHDX	-0.89
LGHL	-0.879
HECCU	-0.879
MTEX	-0.877

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Luminex Corporation 相関 - 通貨/商品

-0.58
( weak negative )

0.24
( neutral )

0.36
( neutral )

-0.28
( neutral )

-0.78
( moderate negative )

0.52
( weak )

Luminex Corporation 財務諸表

Annual	2020
収益:	$417.40M
総利益:	$247.85M (59.38 %)
EPS:	$0.336

FY	2020
収益:	$417.40M
総利益:	$247.85M (59.38 %)
EPS:	$0.336

FY	2019
収益:	$334.64M
総利益:	$182.74M (54.61 %)
EPS:	$-0.0900

FY	2018
収益:	$315.82M
総利益:	$195.49M (61.90 %)
EPS:	$0.420

Financial Reports:

No articles found.

Luminex Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Luminex Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.83 - No dividend growth expected in the near future

Information

First Dividend	$0.0600	2017-03-22
Last Dividend	$0.100	2021-06-16
Next Dividend	$0	N/A
Payout Date	2021-07-08
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	$1.350	--
Avg. Dividend % Per Year	0.22%	--
Score	4.31	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.83
Div. Directional Score	8.48	--

Next Divdend (Est)
(2024-06-27)

$0 Estimate 0.00 %

Dividend Stability

0.14 Bad

Dividend Score

4.31

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2017	$0.240	1.18%
2018	$0.240	1.18%
2019	$0.300	1.32%
2020	$0.370	1.61%
2021	$0.200	0.82%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0363	1.500	9.27	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0197	1.200	9.34	10.00	[0 - 0.3]
returnOnEquityTTM	0.0309	1.500	-0.768	-1.152	[0.1 - 1]
payoutRatioTTM	1.087	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	5.82	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.30	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.54	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.271	-1.500	5.48	-8.21	[0 - 0.6]
interestCoverageTTM	3.56	1.000	9.79	9.79	[3 - 30]
operatingCashFlowPerShareTTM	1.090	2.00	9.64	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.699	2.00	9.65	10.00	[0 - 20]
debtEquityRatioTTM	0.404	-1.500	8.38	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.594	1.000	3.44	3.44	[0.2 - 0.8]
operatingProfitMarginTTM	0.102	1.000	9.97	9.97	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.239	1.000	9.78	9.78	[0.2 - 2]
assetTurnoverTTM	0.542	0.800	9.72	7.78	[0.5 - 2]
Total Score				13.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	111.73	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0309	2.50	-0.494	-1.152	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.699	2.00	9.77	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.090	2.00	9.64	10.00	[0 - 30]
payoutRatioTTM	1.087	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-17.50	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.120	1.000	9.51	0	[0.1 - 0.5]
Total Score				3.83

Luminex Corporation

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.